Company intelligence / Profile preview

Oslo Axess

Ownership: Private
Development stage: Other

Overview

Oslo Axess was a regulated stock market in Norway, operated by the Oslo Stock Exchange (Oslo Børs). Launched in 2007, it was specifically designed for smaller and medium-sized growth companies that sought the benefits of a regulated market but did not yet meet the stringent requirements of the main Oslo Børs listing. It became a prominent listing venue for the Norwegian biotechnology and life sciences sector, hosting companies such as PCI Biotech, Targovax, and Nordic Nanovector. In November 2020, following Euronext's acquisition of Oslo Børs, the marketplace was rebranded as Euronext Expand.

Industry: Investors

Beyond the preview

Go deeper on Oslo Axess.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oslo Axess.

Explore the full profile